0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z search

TeachMeFinance.com - explain cBR96-doxorubicin immunoconjugate cBR96-doxorubicin immunoconjugate A substance that is being studied in the treatment of cancer. It combines a monoclonal antibody with the anticancer drug doxorubicin. Monoclonal antibodies are substances that are made in the laboratory and that can locate and bind to cancer cells. cBR96-doxorubicin immunoconjugate belongs to the family of drugs called antibody drug conjugates. Also called SGN-15. About the author Mark McCracken Author: Mark McCracken is a corporate trainer and author living in Higashi Osaka, Japan. He is the author of thousands of online articles as well as the Business English textbook, "25 Business Skills in English". Copyright © 2005 by Mark McCracken, All Rights Reserved. TeachMeFinance.com is an informational website, and should not be used as a substitute for professional medical, legal or financial advice. Information presented at TeachMeFinance.com is provided on an "AS-IS" basis. Source of definition: The National Cancer Institute. Please read the disclaimer for details.